Manufacturer record
Apple Biotech: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
3 batches manufactured by Apple Biotech (Punjab) were declared Not of Standard Quality between February 2019 and September 2019. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
3 records linked to Apple Biotech in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Mycophenolate Sodium Tablets USP 720 mg (Mycophaz-720 Tablets ) | AT/7822Mfg 2019-02 · Exp 2021-01 | Identification of Mycophenola te SodiumIdentification | RDTL ChandigarhCDSCO lab | Sep 2019 |
| Allopurinol Tablets IP 300 mg (AURINOL-300 TABLETS) | AT/5515Mfg 2018-11 · Exp 2020-10 | Assay and DissolutionAssay | RDTL ChandigarhCDSCO lab | Aug 2019 |
| Fexofenadine Hydrochloride Tablets IP (FEXOFINE-180 TABLETS) | AT/3083Mfg 2018-07 · Exp 2020-06 | Dissolution (After 10 Min), (After 30 min).Dissolution | RDTL ChandigarhCDSCO lab | Feb 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.